PMV PHARMACEUTICALS INC's ticker is PMVP and the CUSIP is 69353Y103. A total of 107 filers reported holding PMV PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $403,146 | -42.2% | 84,517 | +5.5% | 0.00% | -50.0% |
| Q4 2022 | $697,122 | -67.1% | 80,129 | -55.0% | 0.00% | -66.7% |
| Q3 2022 | $2,119,000 | +217.7% | 178,078 | +280.3% | 0.01% | +200.0% |
| Q2 2022 | $667,000 | -56.7% | 46,824 | -29.8% | 0.00% | -73.3% |
| Q4 2021 | $1,542,000 | +30.1% | 66,743 | +67.9% | 0.02% | 0.0% |
| Q3 2021 | $1,185,000 | +199.2% | 39,751 | +242.7% | 0.02% | +275.0% |
| Q2 2021 | $396,000 | – | 11,599 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERWEST VENTURE MANAGEMENT CO | 3,869,911 | $115,323,000 | 47.76% |
| Euclidean Capital LLC | 2,769,813 | $82,540,000 | 40.12% |
| Logos Global Management LP | 1,400,000 | $41,720,000 | 3.01% |
| Orbimed Advisors | 7,330,423 | $218,447,000 | 2.40% |
| Boxer Capital, LLC | 2,268,236 | $67,593,000 | 2.36% |
| PERSONAL CFO SOLUTIONS, LLC | 355,342 | $10,589,000 | 2.17% |
| Asymmetry Capital Management, L.P. | 100,882 | $3,006,000 | 1.81% |
| Avoro Capital Advisors LLC | 2,925,000 | $87,165,000 | 1.37% |
| COMMODORE CAPITAL LP | 125,000 | $3,725,000 | 0.98% |
| HighVista Strategies LLC | 39,777 | $1,185,000 | 0.78% |